GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:23322205
| Citation |
Kaliszczak, M, Trousil, S, Åberg, O, Perumal, M, Nguyen, QD and Aboagye, EO (2013) A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth. Br. J. Cancer 108:342-50 |
|---|---|
| Abstract |
This study investigates whether a histone deacetylase subtype 6 (HDAC6) inhibitor could be used in the treatment of solid tumours. |
| Links |
PubMed PMC3566806 Online version:10.1038/bjc.2012.576 |
| Keywords |
Acetylation/drug effects; Animals; Apoptosis/drug effects; Caspase 3/analysis; Cell Cycle/drug effects; Cell Proliferation/drug effects; Female; Gene Expression/drug effects; HCT116 Cells; HSP90 Heat-Shock Proteins/metabolism; Histone Deacetylase Inhibitors/pharmacology; Histone Deacetylase Inhibitors/therapeutic use; Histone Deacetylases/metabolism; Humans; Hydroxamic Acids/pharmacology; Ki-67 Antigen/analysis; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms/drug therapy; Tubulin/metabolism; Xenograft Model Antitumor Assays |
| edit table |
Significance
Annotations
| Gene product | Qualifier | GO Term | Evidence Code | with/from | Aspect | Extension | Notes | Status |
|---|---|---|---|---|---|---|---|---|
| GO:0004407: histone deacetylase activity |
ECO:0000315: |
F |
see figure 2 to experimental results that show the proteins ablity to deacetylase activity |
complete | ||||
|
enables |
GO:0004407: histone deacetylase activity |
ECO:0000315: mutant phenotype evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
See also
References
See Help:References for how to manage references in GONUTS.
